We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Promising Preclinical Results for Compound to Treat Wilson's Disease

News   Jun 28, 2018 | Original story from Cold Spring Harbor Laboratory (CSHL)

 
Promising Preclinical Results for Compound to Treat Wilson's Disease

Liver complications in Wilson's disease include enlarged cell size, irregular shape and arrangement in liver tissue (left image). Treatment with DPM-1001 reversed these pathologies in a Wilson's disease mouse model (right image) and led to dramatic lowering of tissue copper levels. Credit: Tonks Lab, CSHL

 
 
 

RELATED ARTICLES

Party 'Pus: Ecstasy Makes Octopuses More Social

News

When people take MDMA, the drug popularly known as ecstasy, a rush of serotonin, dopamine, and oxytocin makes people more interested than they would normally be in connecting and sharing with other people. Now, researchers have made the surprising discovery that a species of octopus considered to be asocial responds to MDMA in the same way.

READ MORE

Ovarian Cancer Biomarker Can Predict Patient Therapy Response

News

Researchers have identified an independent prognostic factor - cancer/testis antigen 45 (CT45) - and have begun to elucidate it's actions. CT45 is associated with extended disease-free survival for women with advanced ovarian cancer.

READ MORE

Probing Yeast Cells to Understand Cell Misregulation

News

Manipulating yeast with optogenetics and microfluidics to explore the MAP kinase pathway may be key for drug discovery.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE